skip to content
Bad pharma : how drug companies mislead doctors and harm patients Preview this item
ClosePreview this item
Checking...

Bad pharma : how drug companies mislead doctors and harm patients

Author: Ben Goldacre
Publisher: New York : Faber and Faber, Inc., an affiliate of Farrar, Straus and Giroux, 2013. ©2012
Edition/Format:   Book : English : First American editionView all editions and formats
Database:WorldCat
Summary:
We like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Subjects
More like this

 

Find a copy in the library

&AllPage.SpinnerRetrieving; Finding libraries that hold this item...

Details

Document Type: Book
All Authors / Contributors: Ben Goldacre
ISBN: 9780865478008 0865478007
OCLC Number: 814389713
Description: xvii, 426 pages : illustrations ; 22 cm
Contents: Intro --
Missing data --
Where do new drugs come from? --
Bad regulators --
Bad trials --
Bigger, simpler trials --
Marketing --
Afterword: better data.
Responsibility: Ben Goldacre.

Abstract:

We like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct on a global scale affects us. This book reveals a shockingly broken system and calls for something to be done.--From publisher description.

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Linked Data


<http://www.worldcat.org/oclc/814389713>
library:oclcnum"814389713"
library:placeOfPublication
owl:sameAs<info:oclcnum/814389713>
rdf:typeschema:Book
schema:about
<http://id.loc.gov/authorities/subjects/sh85039713>
rdf:typeschema:Intangible
schema:name"Pharmaceutical industry--Moral and ethical aspects."@en
schema:about
schema:about
schema:about
schema:about
schema:about
<http://id.loc.gov/authorities/subjects/sh85039755>
rdf:typeschema:Intangible
schema:name"Drugs--Testing--Moral and ethical aspects."@en
schema:name"Drugs--Testing."@en
schema:about
<http://id.worldcat.org/fast/1060163>
rdf:typeschema:Intangible
schema:name"Pharmaceutical industry--Moral and ethical aspects"@en
schema:name"Pharmaceutical industry--Moral and ethical aspects."@en
schema:about
<http://id.worldcat.org/fast/898948>
rdf:typeschema:Intangible
schema:name"Drugs--Testing--Moral and ethical aspects"@en
schema:name"Drugs--Testing--Moral and ethical aspects."@en
schema:about
schema:about
<http://id.worldcat.org/fast/898891>
rdf:typeschema:Intangible
schema:name"Drugs--Quality control"@en
schema:name"Drugs--Quality control."@en
schema:about
schema:about
<http://id.worldcat.org/fast/864436>
rdf:typeschema:Intangible
schema:name"Clinical trials--Moral and ethical aspects"@en
schema:name"Clinical trials--Moral and ethical aspects."@en
schema:about
schema:bookEdition"First American edition."
schema:copyrightYear"2012"
schema:creator
schema:datePublished"2013"
schema:description"We like to imagine that medicine is based on evidence and the results of fair tests. In reality, those tests are often profoundly flawed. We like to imagine that doctors are familiar with the research literature about a drug, when in reality much of the research is hidden from them by drug companies. We like to imagine that doctors are impartially educated, when in reality much of their education is funded by the pharmaceutical industry. We like to imagine that regulators let only effective drugs onto the market, when in reality they approve useless drugs, with data on side effects casually withheld from doctors and patients. All these problems have been shielded from public scrutiny because they're too complex to capture in a sound bite. But Ben Goldacre shows that the true scale of this murderous disaster fully reveals itself only when the details are untangled. He believes we should all be able to understand precisely how data manipulation works and how research misconduct on a global scale affects us. This book reveals a shockingly broken system and calls for something to be done.--From publisher description."@en
schema:description"Intro -- Missing data -- Where do new drugs come from? -- Bad regulators -- Bad trials -- Bigger, simpler trials -- Marketing -- Afterword: better data."@en
schema:exampleOfWork<http://worldcat.org/entity/work/id/1149471215>
schema:inLanguage"en"
schema:name"Bad pharma : how drug companies mislead doctors and harm patients"@en
schema:url
schema:workExample

Content-negotiable representations

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.